176 related articles for article (PubMed ID: 15921802)
21. Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients.
Agostoni P; Guazzi M; Bussotti M; De Vita S; Palermo P
Chest; 2002 Dec; 122(6):2062-7. PubMed ID: 12475848
[TBL] [Abstract][Full Text] [Related]
22. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
23. Carvedilol: the new role of beta blockers in congestive heart failure.
Vanderhoff BT; Ruppel HM; Amsterdam PB
Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
[TBL] [Abstract][Full Text] [Related]
25. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
26. Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol.
Corrà U; Mezzani A; Giordano A; Bosimini E; Giannuzzi P
Eur Heart J; 2009 Dec; 30(24):3000-6. PubMed ID: 19406866
[TBL] [Abstract][Full Text] [Related]
27. [The effects of beta-adrenoblocker therapy on the physical working capacity of patients with chronic heart failure of various origin].
Poltavskaia MG; Syrkin AL; Andreev DA; Svet AV; Sarkisova EA; Kalashnikov VIu
Klin Med (Mosk); 2007; 85(5):37-41. PubMed ID: 17665602
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure.
Ingle L; Goode K; Carroll S; Sloan R; Boyes C; Cleland JG; Clark AL
Int J Cardiol; 2007 Jun; 118(3):350-5. PubMed ID: 17067694
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of the cardiopulmonary exercise test in patients with heart failure who have been treated with beta-blockers.
Dufay-Bougon C; Belin A; Dahdouh ZS; Barthelemy S; Mabire JP; Sabatier R; Milliez P; Grollier G
Turk Kardiyol Dern Ars; 2013 Mar; 41(2):105-12. PubMed ID: 23666296
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy.
Tabet JY; Metra M; Thabut G; Logeart D; Cohen-Solal A
Am J Cardiol; 2006 Aug; 98(4):500-3. PubMed ID: 16893705
[TBL] [Abstract][Full Text] [Related]
31. Effect of selective and non-selective beta-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure.
Kovacić D; Marinsek M; Gobec L; Lainscak M; Podbregar M
Clin Res Cardiol; 2008 Jan; 97(1):24-31. PubMed ID: 17694376
[TBL] [Abstract][Full Text] [Related]
32. Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
Racine N; Blanchet M; Ducharme A; Marquis J; Boucher JM; Juneau M; White M
J Card Fail; 2003 Aug; 9(4):296-302. PubMed ID: 13680550
[TBL] [Abstract][Full Text] [Related]
33. Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol.
Corrà U; Mezzani A; Bosimini E; Scapellato F; Temporelli PL; Eleuteri E; Giannuzzi P
Am Heart J; 2004 Mar; 147(3):553-60. PubMed ID: 14999209
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
[TBL] [Abstract][Full Text] [Related]
35. Effects of beta-blocker therapy on high sensitivity c-reactive protein, oxidative stress, and cardiac function in patients with congestive heart failure.
Nagatomo Y; Yoshikawa T; Kohno T; Yoshizawa A; Anzai T; Meguro T; Satoh T; Ogawa S
J Card Fail; 2007 Jun; 13(5):365-71. PubMed ID: 17602983
[TBL] [Abstract][Full Text] [Related]
36. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
37. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
38. Dyspnoea versus fatigue: additional prognostic information from symptoms in chronic heart failure?
Witte KK; Clark AL
Eur J Heart Fail; 2008 Dec; 10(12):1224-8. PubMed ID: 18996048
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
[TBL] [Abstract][Full Text] [Related]
40. A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade.
Takahama H; Asanuma H; Sanada S; Fujita M; Sasaki H; Wakeno M; Kim J; Asakura M; Takashima S; Minamino T; Komamura K; Sugimachi M; Kitakaze M
Basic Res Cardiol; 2010 Nov; 105(6):787-94. PubMed ID: 20852875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
